Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer

NCT03843918 is registered in ClinicalTrials.gov with Laekna Limited as lead sponsor.

NCT NCT03843918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03843918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer
Lead sponsor
Laekna Limited
Phase
Phase 1/2
Overall status
Terminated
Start date
April 5, 2019
Completion date
October 9, 2023
Enrollment
33 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer metastatic